AMRX
Amneal·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
AMRX Filings
Filing Date
Form Description
Form Type
2025-11-19
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2025-11-19 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2025-11-17
Form 144 - Report of proposed sale of securities
Ownership
2025-11-17 · Ownership
Form 144 - Report of proposed sale of securities
2025-11-14
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2025-11-14 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2025-11-12
Form 144 - Report of proposed sale of securities
Ownership
2025-11-12 · Ownership
Form 144 - Report of proposed sale of securities
2025-11-06
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Financials
2025-11-06 · Financials
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025-10-30
Amneal Pharmaceuticals, Inc. (AMRX) Q3 2025 Earnings Call Transcript
Earnings Call
2025-10-30 · Earnings Call
Amneal Pharmaceuticals, Inc. (AMRX) Q3 2025 Earnings Call Transcript
2025-10-30
Form 8-K - Current report
Key Events
2025-10-30 · Key Events
Form 8-K - Current report
2025-10-07
Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2025-10-07 ·
Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2025-10-06
Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2025-10-06 ·
Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2025-08-28
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2025-08-28 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
